The brain stuff was the symptom that scared me most. Forgetting words mid-sentence, walking into rooms and going completely blank — it felt like something was seriously wrong, not like a hormone story. Finding out there was a supplement with real trial data behind it, not just wellness marketing, felt like a small but meaningful handhold during a time when very little felt solid.
Learn more about Rose →Phosphatidylserine (PS) is a phospholipid — a fat molecule — that makes up a significant portion of the outer layer of neurons, particularly in the brain's prefrontal cortex and hippocampus. It plays a direct role in cell-to-cell signalling, neurotransmitter release, and the maintenance of membrane fluidity, all of which are essential for clear thinking and memory retrieval. The body can synthesise it, but production declines with age, which is part of why supplementation has attracted serious research interest.
The US Food and Drug Administration granted phosphatidylserine a qualified health claim in 2003, stating it 'may reduce the risk of dementia and cognitive dysfunction in the elderly' — one of the very few supplements to receive this designation. The qualification is based on a body of clinical trials, though the FDA notes the evidence is limited rather than conclusive. For perimenopausal women tracking supplements carefully, this regulatory acknowledgement is meaningful context that PS is not fringe territory.
Multiple randomised controlled trials have found that PS supplementation — typically 300–400 mg daily over 6–12 weeks — produced statistically significant improvements in memory tasks, particularly name-face association and word recall, compared to placebo. A notable 1991 trial published in Neurology by Crook et al. showed improvements in people with age-associated memory impairment, with the strongest effects in those with the most significant baseline deficits. Word recall difficulties are among the most commonly reported cognitive symptoms in perimenopause, which makes this specific finding directly relevant.
One of PS's most well-documented effects is its ability to dampen the hypothalamic-pituitary-adrenal (HPA) axis response to stress, resulting in measurably lower cortisol and ACTH levels after physical and psychological stressors. A 1992 study by Monteleone et al. found that 800 mg of PS significantly blunted cortisol and ACTH rises in response to exercise stress. During perimenopause, when oestrogen fluctuation already dysregulates the HPA axis and cortisol tends to run chronically elevated, this mechanism is particularly relevant.
Declining oestrogen disrupts the hippocampus — the brain region most dependent on oestrogen receptors for memory consolidation — while simultaneously increasing HPA axis reactivity and cortisol output. Elevated cortisol further damages hippocampal neurons in a feedback loop that worsens both memory and mood. Phosphatidylserine addresses both sides of this equation: supporting neuronal membrane integrity in oestrogen-deprived brain tissue and reducing the cortisol load that compounds the damage.
Early clinical trials, including most of the gold-standard memory research, used phosphatidylserine derived from bovine cortex (cow brain), which has a fatty acid profile closely matching human brain PS. Due to BSE (mad cow disease) concerns, commercial production shifted to soy-derived PS in the 1990s, and more recently sunflower-derived PS has become available for those avoiding soy. Soy-derived PS has its own positive trial data, though some researchers note its fatty acid profile differs slightly from bovine PS, and whether this affects efficacy remains an open question.
The majority of positive clinical trials used 300 mg per day, typically administered as 100 mg three times daily with meals — a dosing schedule thought to improve absorption since PS is fat-soluble. Some studies used doses up to 800 mg for cortisol-blunting effects, though most cognitive benefit research clusters around the 300–400 mg range. Taking it with a fat-containing meal supports absorption, which is worth noting for anyone who tends to take supplements on an empty stomach.
PS is generally well tolerated in clinical trials, with no serious adverse events reported at standard doses and a side effect profile comparable to placebo. However, it has mild anticoagulant properties and may interact with blood-thinning medications including warfarin and aspirin — worth flagging with a prescriber for anyone on those therapies. There is also theoretical interaction with anticholinergic drugs, since PS influences acetylcholine activity, though clinical evidence for this interaction is limited.
Phosphatidylserine works downstream — it supports the neuronal environment and moderates cortisol, but it does not replace oestrogen, restore sleep architecture, or address the root hormonal cause of perimenopausal cognitive symptoms. For women whose brain fog is primarily oestrogen-driven, the evidence for hormone therapy in protecting cognitive function is substantially stronger than for any supplement. PS is most usefully framed as a meaningful adjunct — particularly for women who cannot or choose not to use HRT, or who are using it alongside other evidence-based strategies.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.